Target intelligence / Profile preview

Indium-111 (111In)

Target
111In
Molecular classification
Other (radioisotope, radiotracer, not a biological macromolecule, not a receptor or enzyme)
01

Overview

Indium-111 is a radioactive isotope of indium that decays by electron capture to stable cadmium-111 with a physical half-life of approximately 2.8 days (67.2 hours)[1][4][9][10]. It emits gamma photons at energies of 171 keV and 245 keV, making it suitable for detection through gamma cameras and SPECT imaging[1][4][5][9]. Indium-111 is not a biological target (such as a receptor, enzyme, or transporter) but is a radioisotope used as a diagnostic tracer in nuclear medicine. It is commonly used to label biological molecules, cells, antibodies, or peptides for imaging the localization of tumors (e.g., indium-111 pentetreotide for neuroendocrine tumors), sites of infection, or inflammation (e.g., indium-111-labeled leukocytes)[5][6][7]. As such, "Indium-111 decay emission tracer" is not a canonical biological target, but rather the radioisotope component of diagnostic radiopharmaceuticals. It does not have intrinsic biological function or act as a "therapeutic target"[1][6][7][9]. Summary of errors/limitations in the target name "Indium-111 decay emission tracer": - It is not a therapeutic target, but a radioactive tracer (false positive as a target)[1][7]. - It is properly referred to as "Indium-111" or "111In" in the context of radiopharmaceuticals[1][6][7]. - Its function, safety, and disease associations depend on the ligand or construct to which it is attached (e.g., octreotide, antibodies, leukocytes)[5][6][7]. - No canonical therapeutic drugs "interact" with indium-111 as a target; instead, drugs or biomolecules are labeled with it for imaging[7]. - Molecular classification is "Other" (radioisotope), not receptor, enzyme, transporter, etc. If you are seeking information on a nuclear medicine imaging tracer labeled with indium-111 (such as "indium-111 pentetreotide" or "indium-111 chloride-labeled leukocytes"), you should specify the biomolecule or target rather than the decay emission tracer itself. Indium-111 is an imaging tool, not a molecular therapeutic target[1][5][6][7][9].

Other names
Indium-111 tracer111In radiotracerIndium-111 emissionIndium-111 chlorideIndium-111 pentetreotide (when chelated to peptides)Indium-111 oxyquinoline (when chelated for cell labeling)111In tracer
02

Mechanism of action

*Not applicable*; indium-111 acts as a gamma-emitting radioisotope detected in radiopharmaceuticals[1][6][7] - Mechanism depends on the compound it labels (e.g., binds somatostatin receptor in case of 111In-pentetreotide[6])

03

Biological functions

*Not applicable* (functions as a radioactive tracer for diagnostic imaging, not as a cellular macromolecule)
04

Disease associations

Other (used to image or track a variety of diseases but not a causal role in disease itself)Cancer (for tumor imaging[6][7])Infection (for imaging infection/inflammation[7])Inflammation (for labeling leukocytes to track inflammation[5][7])Neuroendocrine disease (for tumor imaging[6])
05

Safety considerations

External radiation hazard due to gamma emission[4][5]Radiation exposure to patient and personnel[4][5]Special shielding/handling requirements in nuclear medicine[4][5]Not therapeutic; improper use can result in unnecessary radiation dose
06

Interacting drugs

*Not applicable*; indium-111 binds to chelators for imaging, not as a drug target (see below for labeled agents)
07

Biomarkers

*Not applicable* as a standalone molecule; used as a label for various diagnostic biomarkers, such as:White blood cells for infection/inflammation[7]Peptides/antibodies for tumor or receptor imaging[6][7]

Beyond the preview

Go deeper on Indium-111 (111In).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indium-111 (111In).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call